Procter Long Term Investments vs Other Liab Analysis
PG Stock | USD 161.29 1.26 0.78% |
Procter Gamble financial indicator trend analysis is much more than just breaking down Procter Gamble prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Procter Gamble is a good investment. Please check the relationship between Procter Gamble Long Term Investments and its Other Liab accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Procter Gamble. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in Procter Stock please use our How to Invest in Procter Gamble guide.
Long Term Investments vs Other Liab
Long Term Investments vs Other Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Procter Gamble Long Term Investments account and Other Liab. At this time, the significance of the direction appears to have weak relationship.
The correlation between Procter Gamble's Long Term Investments and Other Liab is 0.39. Overlapping area represents the amount of variation of Long Term Investments that can explain the historical movement of Other Liab in the same time period over historical financial statements of Procter Gamble, assuming nothing else is changed. The correlation between historical values of Procter Gamble's Long Term Investments and Other Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Investments of Procter Gamble are associated (or correlated) with its Other Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Liab has no effect on the direction of Long Term Investments i.e., Procter Gamble's Long Term Investments and Other Liab go up and down completely randomly.
Correlation Coefficient | 0.39 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Long Term Investments
Long Term Investments is an item on the asset side of Procter Gamble balance sheet that represents investments Procter Gamble intends to hold for over a year. Procter Gamble long term investments may include different instruments such as stocks, bonds, real estate and cash.Other Liab
Most indicators from Procter Gamble's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Procter Gamble current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Procter Gamble. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in Procter Stock please use our How to Invest in Procter Gamble guide.At this time, Procter Gamble's Sales General And Administrative To Revenue is most likely to slightly decrease in the upcoming years. The Procter Gamble's current Enterprise Value is estimated to increase to about 242.2 B, while Enterprise Value Over EBITDA is projected to decrease to 10.60.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 38.0B | 39.2B | 45.1B | 28.5B | Total Revenue | 80.2B | 82.0B | 94.3B | 58.8B |
Procter Gamble fundamental ratios Correlations
Click cells to compare fundamentals
Procter Gamble Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Procter Gamble fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 120.7B | 119.3B | 117.2B | 120.8B | 139.0B | 84.3B | |
Short Long Term Debt Total | 34.7B | 32.0B | 31.5B | 34.6B | 39.8B | 22.3B | |
Other Current Liab | 3.1B | 3.1B | 9.6B | 10.9B | 12.6B | 13.2B | |
Total Current Liabilities | 33.0B | 33.1B | 33.1B | 35.8B | 41.1B | 21.0B | |
Total Stockholder Equity | 46.9B | 46.7B | 46.9B | 47.1B | 54.1B | 36.7B | |
Property Plant And Equipment Net | 20.7B | 21.7B | 21.2B | 21.9B | 25.2B | 16.8B | |
Net Debt | 18.5B | 21.7B | 24.3B | 26.4B | 30.3B | 17.6B | |
Retained Earnings | 100.2B | 106.4B | 112.4B | 118.2B | 135.9B | 142.7B | |
Cash | 16.2B | 10.3B | 7.2B | 8.2B | 9.5B | 10.0B | |
Non Current Assets Total | 92.7B | 96.2B | 95.6B | 98.2B | 112.9B | 65.5B | |
Non Currrent Assets Other | 8.3B | 10.0B | 4.0B | 11.8B | 13.6B | 14.3B | |
Cash And Short Term Investments | 16.2B | 10.3B | 7.2B | 8.2B | 9.5B | 6.0B | |
Net Receivables | 4.2B | 4.7B | 5.1B | 5.5B | 6.3B | 4.5B | |
Common Stock Shares Outstanding | 2.6B | 2.6B | 2.5B | 2.5B | 2.2B | 2.3B | |
Liabilities And Stockholders Equity | 120.7B | 119.3B | 117.2B | 120.8B | 139.0B | 84.3B | |
Non Current Liabilities Total | 40.8B | 39.5B | 37.3B | 38.0B | 43.7B | 26.5B | |
Inventory | 5.5B | 6.0B | 6.9B | 7.1B | 8.1B | 5.1B | |
Other Current Assets | 2.1B | 2.1B | 2.4B | 1.9B | 2.1B | 2.8B | |
Other Stockholder Equity | (41.0B) | (49.8B) | (57.3B) | (63.7B) | (57.3B) | (54.5B) | |
Total Liab | 73.8B | 72.7B | 70.4B | 73.8B | 84.8B | 47.5B | |
Total Current Assets | 28.0B | 23.1B | 21.7B | 22.6B | 26.0B | 18.9B | |
Short Term Debt | 11.2B | 8.9B | 8.6B | 10.2B | 11.8B | 7.1B | |
Intangible Assets | 23.8B | 23.6B | 23.7B | 23.8B | 27.4B | 18.9B | |
Accounts Payable | 12.1B | 13.7B | 14.9B | 14.6B | 16.8B | 17.6B | |
Good Will | 39.9B | 40.9B | 39.7B | 40.7B | 46.8B | 37.0B | |
Property Plant And Equipment Gross | 20.7B | 21.7B | 46.7B | 48.6B | 55.9B | 58.7B | |
Accumulated Other Comprehensive Income | (17.2B) | (14.8B) | (13.1B) | (12.2B) | (11.0B) | (11.5B) | |
Current Deferred Revenue | 5.4B | 6.7B | 6.6B | 7.4B | 8.5B | 6.3B | |
Other Liab | 16.7B | 16.4B | 14.4B | 13.6B | 15.7B | 11.2B | |
Other Assets | 7.4B | 10.0B | 11.0B | 11.0B | 12.7B | 13.3B | |
Long Term Debt | 23.5B | 23.1B | 22.8B | 24.4B | 28.0B | 21.3B | |
Property Plant Equipment | 21.5B | 21.7B | 21.2B | 21.9B | 25.2B | 20.7B | |
Treasury Stock | (105.6B) | (115.0B) | (123.4B) | (129.7B) | (116.8B) | (122.6B) | |
Net Tangible Assets | (18.1B) | (17.9B) | (16.5B) | (18.5B) | (21.3B) | (22.3B) |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Procter Gamble using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Procter Gamble. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in Procter Stock please use our How to Invest in Procter Gamble guide.Note that the Procter Gamble information on this page should be used as a complementary analysis to other Procter Gamble's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Procter Stock analysis
When running Procter Gamble's price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
CEOs Directory Screen CEOs from public companies around the world | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Procter Gamble's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procter Gamble. If investors know Procter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procter Gamble listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.106 | Dividend Share 3.763 | Earnings Share 6.11 | Revenue Per Share 35.616 | Quarterly Revenue Growth 0.006 |
The market value of Procter Gamble is measured differently than its book value, which is the value of Procter that is recorded on the company's balance sheet. Investors also form their own opinion of Procter Gamble's value that differs from its market value or its book value, called intrinsic value, which is Procter Gamble's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procter Gamble's market value can be influenced by many factors that don't directly affect Procter Gamble's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procter Gamble's value and its price as these two are different measures arrived at by different means. Investors typically determine if Procter Gamble is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procter Gamble's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.